Promore Pharma

Promore Pharma is a privately held clinical-stage biopharmaceutical company developing state-of-the-art products, based on therapeutic peptides, for local or topical treatment of infections and wounds.

Promore Pharma’s strategy is to initiate partnering discussions for development programs once they have achieved clinical proof of concept. Targeted partners are mid to large-size pharmaceutical companies. Promore Pharma also evaluates other strategic partnering opportunities as they occur, and welcomes interest from potential partners in any ongoing project.